BI 3720931 is a first-in-class, inhaled lentiviral vector-based gene therapy that could potentially address unmet needs by inserting a functional copy of the CFTR gene in the DNA of airway epithelial ...
Quisitive Technology Solutions, Inc. ("Quisitive" or the "Company") is pleased to announce that two leading independent proxy advisory firms, including Institutional Shareholder Services Inc. ("ISS"), ...
Global Mapper v26.1 introduces AI-powered deep learning enhancements, improved point cloud processing, and streamlined user tools.
The 31,000-mile cable will connect parts of the US, Brazil, South, Africa, and India. Project Waterworth should be online by ...
The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...
Jupyter “sandbox escapes”: In another example of “Shadow ML,” many data scientists today rely on Jupyter Notebook, which can ...
Results from OVATION 2 Study continue to validate TheraPlas® technology, demonstrating DNA-mediated production of key anti-cancer immune cytokines following treatment IMNN-001 continues to show ...
At the heart of this ecosystem is the AP3X token, which simplifies operations by eliminating the need for multiple assets, ...
The Cool Down on MSN2d
Scientists may have just saved the citrus industry — and kept your grocery bill from skyrocketingThis breakthrough is being called “one of the most promising discoveries to date." Scientists may have just saved the citrus industry — and kept your grocery bill from skyrocketing first appeared on ...
The company is one of the leading Indian multinational specialty performance chemical producers and provides sustainable, ...
Detailed price information for Kovo+ Holdings Inc (KOVO-X) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback